French contract research organisation providing high added value R&D services in development and production of monoclonal antibodies, recombinant proteins, DNA plasmids, genetic & cell engineering : manufacturing / subcontracting agreements sought

The French CRO (contract research organisation) offers high value custom services for the development, engineering and production of antibodies, recombinant proteins, plasmids & vectors, cells, immunoassays & bioassays. New manufacturing and subcontracting agreements are sought with companies or universities or research institutions working in biotechnology, diagnostics, healthcare, cosmetics, pharmacology willing to develop new tests or kits.
As a center of excellence in monoclonal antibody research and immunoassay kit development, the French company is offering its strong know-how and expertise under manufacturing or subcontracting agreements to develop new tests, immunoassay kits, products such as vaccines for companies or biomanufacturing processes working in the fields of biotechnology, diagnostics, healthcare, cosmetics, pharmacology, or universities and research institutions The core of this know-how and expertise covers : Manufacturing in R&D, preclinical and high quality grades of DNA (desoxyribonucleic acid) plasmids and monoclonal antibodies. Recombinant protein expression in several systems: cell free, CHO (Chinese Hamster Ovary), HEK(Human embryonic kidney) and E.Coli systems, including vector design and construction. Monoclonal antibody generation: Hybridoma and Phage display platforms (mouse, llama) Platform of Antibody Engineering: Antibody sequencing, chimerisation, humanization and reformatting (scFv - single chain variable fragment, Fab -antigen binding, bispecific…), characterization & production. Analytical services: for lead screening, for antibody validation and characterization, amongst other: ELISA (enzyme-linked immunoabsorbent assay), FACS (fluorescence activated cell sorting), Octet system, PCR assays (polymerase chain reaction) ...and a bioassay platform. FastELISA kits for IgG (immunoglobins G) quantification (mouse, human, rat), for Ig -immunoglobin isotyping or for contaminant detection (protein A, bovine IgG): the most convenient method, ready-to-use, to quantify IgG with results in only 30 minutes! The company can answer rigorously to the specifications brought by the customers but also has a proven projects management process including the study, the scientific expertise, faisability study, protocol definition, ... The process can be deployed for only specific stages or globally.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
The French company provides its custom R&D services to companies in the fields of biotechnology, diagnostics, healthcare, cosmetics, pharmacology, or universities and research institutions that are developing tests or products and that need antibodies, recombinants proteins, DNA plasmids, cells or skills in Immunology, biochemistry, molecular biology or cell engineering. The company has also collaborated with various public research institutions within funded (international) R&D projects where its know-how has been utilized to reach common goals. Thus, new partners might be active in the above-mentioned fields, but also in other relevant ones. New manufacturing and subcontracting agreements are sought to develop new custom products where the French company can bring its high added value custom R&D services from conception to the manufacturing of the product.
Stage of Development: 
Under development/lab tested
Comments Regarding Stage of Development: 
R&D or preclinical, lab tested
IPR Status: 
Secret Know-how
External code: